Tuberculosis Global Clinical Trials Review, H2, 2013
br /Introduction 7 Tuberculosis 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Five Countries Contributing to
br />Introduction 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Tuberculosis 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Otsuka Pharmaceutical Co., Ltd. 35
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 35
Janssen Infectious Diseases 36
Clinical Trial Overview of Janssen Infectious Diseases 36
Tibotec BVBA 37
Clinical Trial Overview of Tibotec BVBA 37
Alaeras, Inc 38
Clinical Trial Overview of Alaeras, Inc 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vakzine Projekt Management GmbH 40
Clinical Trial Overview of Vakzine Projekt Management GmbH 40
Intercell AG 41
Clinical Trial Overvi '/>"/>
(Date:5/28/2015)... May 28, 2015 Natera, Inc., a ... study published in Ultrasound in Obstetrics & ... (SNP)-based non-invasive prenatal test (NIPT) can identify a ... A study based upon data collected ... occur in about 1 in 1,000 pregnancies, although ...
(Date:5/28/2015)... Mass. , May 28, 2015 RXi ... focused on discovering and developing innovative therapeutics, primarily in ... pricing of a public offering of 26 million units ... share for gross proceeds of approximately $10.4 million. Each ... (ii) a 13-month overallotment purchase right to purchase 0.50 ...
(Date:5/28/2015)... The Fertility Centers of New England is ... has taken on a new and expanded role as ... guidance, leadership, oversight and quality assurance for the practice. ... our team of experienced reproductive endocrinologists,” said Fertility Centers ... M.D. “Her expertise and compassionate, individualized care have helped ...
(Date:5/28/2015)... May 28, 2015 American Process ... (Oak Ridge, TN) recently signed a joint ... printing plastic resins using nanocellulose, a rapidly emerging ... 3D printing is the limited number of feedstock ... mechanical strength to printed parts for load bearing ...
... May 9, 2011 The U.S. Food and Drug Administration ... to the development of a user fee program for ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Biological products ... microorganism, plant, or animal cell, while small molecule drugs ...
... On May 17-18, 2011, Diversity Alliance for Science, ... and develop minority-, woman-, veteran/service-disabled-, HUBZone-, and LGBT-owned, ... networking conference and EXPO event. The two-day event ... Hotel in Newark, N.J. and will feature senior ...
... SAN DIEGO, May 9, 2011 Ardea Biosciences, Inc. ... on the development of small-molecule therapeutics for the treatment ... results for the first quarter ended March 31, 2011. ... lesinurad in combination with allopurinol demonstrate lesinurad,s potential to ...
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Recognition Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by ... End User (Government and Utilities, Consumer and Home) - ... Market to grow from $2.77 Billion in 2015 to ... Browse 79 market data Tables and ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year. The course will focus ...
(Date:5/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... owned subsidiary, 3D-ID LLC, a company engaged in biometric ... the biometrics technology portion of the recently awarded TIES ... Department of the Army. 3D-ID LLC has ... government, law enforcement and security agencies. ...
... studying pigeons with genetic heart disease, researchers at Wake ... about why some patients' heart vessels are prone to ... a regulator of genes that controls the growth of ... researcher. "Learning to modulate the uncontrolled growth of these ...
... Northwestern University research group has discovered that aggressive ... critical to proper embryo formation. , An ... the advanced online issue of the journal Nature ... embryonic growth factor by injecting aggressive melanoma cells ...
... norepinephrine levels in the brains of rats to ... in the sensory pathways to make it easier ... team has found. , Their report in the ... aids people with attention deficit and hyperactivity disorders ...
... Stem cells are functionally defined by ... ability to differentiate into multiple specialized progenitor ... along specific lineages. Neural stem cells (NSCs) ... types including astrocytes, neurons and oligodendrocytes. During ...